Infection Prevention and Control
Infection prevention and control indicators 2025-2026
Vitalité Health Network closely monitors certain indicators related to infection prevention and control in its facilities. This monitoring helps identify trends, support clinical teams and strengthen practices that contribute to safe care.
For 2025-2026, the Network recorded 62 cases of C. difficile infection, representing a rate of 1.71 per 10,000 patient-days. This intestinal infection can occur in some hospitalized patients, particularly following the use of antibiotics.
The Network also recorded 3 MRSA infections, for a rate of 0.08 per 10,000 patient-days. When including situations where patients were carrying MRSA, with or without signs of infection, 8 cases of MRSA colonization or infection were observed, for a rate of 0.22 per 10,000 patient-days.
For VRE, another bacterium resistant to certain antibiotics, 1 infection was recorded during the year, for a rate of 0.03 per 10,000 patient-days. In total, 3 cases of VRE colonization or infection were observed, for a rate of 0.08 per 10,000 patient-days.
Rates per 10,000 patient-days make it possible to take into account the volume of activity in facilities and to monitor changes in infections from one period to another.
Hand hygiene
Hand hygiene remains one of the simplest and most effective ways to reduce the risk of infection transmission in health care settings. Vitalité Health Network monitors this indicator across its zones to encourage good practices and identify opportunities for improvement.
For 2025-2026, the observed hand hygiene rates were 65% in Zone 1, 91% in Zone 4, 88% in Zone 5 and 81% in Zone 6.
These results show the importance of continuing awareness, support and continuous improvement efforts across the Network.
Commitment to prevention
These indicators are regularly monitored by infection prevention and control teams. They help guide prevention efforts, including hand hygiene, environmental cleaning, the appropriate use of personal protective equipment and the monitoring of health care-associated infections.